Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
WorldWebinar

Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials


Add this event to your calendar: iCal   Google Calendar

Who should attend?

VPs, Directors, and Managers from biopharmaceutical companies and contract research organizations working within NASH clinical research

Details

Non-alcoholic fatty liver disease (NAFLD) is a medical condition characterized by the build-up of fat in the liver. NAFLD has a spectrum that ranges from steatosis and non-alcoholic steatohepatitis (NASH) to fibrotic NASH and cirrhosis.

Prices

free

Contact

Fridha Bonilla
fbonilla@xtalks.com

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.